Sfoglia per Autore
Mostrati risultati da 1 a 6 di 6
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials
2018 Arcangeli, G; Arcangeli, S; Pinzi, V; Benassi, M; Benassi, M; Strigari, L
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies
2017 Rotiroti, M; Arcangeli, S; Casucci, M; Perriello, V; Bondanza, A; Biondi, A; Tettamanti, S; Biagi, E
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
2017 Arcangeli, S; Rotiroti, M; Bardelli, M; Simonelli, L; Magnani, C; Biondi, A; Biagi, E; Tettamanti, S; Varani, L
Optimization of Chimeric Antigen Receptor (CAR) design strategy for a specific anti-CD123 targeted therapy in pediatric Acute Myeloid Leukemia (AML)
2016 Arcangeli, S
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo
2013 Bertilaccio, M; Tettamanti, S; Attianese, G; Galletti, G; Arcangeli, S; Rodriguez, T; Magnani, C; Barbaglio, F; Scarfò, L; Ponzoni, M; Biondi, A; Caligaris Cappio, F; Biagi, E; Ghia, P
Mostrati risultati da 1 a 6 di 6
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile